We are live on
!
Find out more
CTC
Central Trust Company Portfolio holdings
AUM
$5.08B
1-Year Est. Return
25.65%
This Fund
S&P 500
This Quarter
Est. Return
+8.56%
1 Year Est. Return
+25.65%
3 Year Est. Return
+74.65%
5 Year Est. Return
+97.11%
10 Year Est. Return
+319.6%
AUM
$1.95B
AUM Growth
+$180M
(+10%)
Cap. Flow
+$43.9M
Cap. Flow
% of AUM
2.25%
Top 10 Holdings %
Top 10 Hldgs %
24.71%
Holding
1,252
New
88
Increased
327
Reduced
360
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Mid-Cap Value ETF
VOE
|
+$4.63M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$4.52M |
| 3 |
Truist Financial
TFC
|
+$4.46M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$4.38M |
| 5 |
iShares Gold Trust
IAU
|
+$4.19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$6.79M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$4.4M |
| 3 |
Apple
AAPL
|
+$2.01M |
| 4 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$1.9M |
| 5 |
Vanguard Morningstar Small-Cap Growth ETF
VBK
|
+$1.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.21% |
| 2 | Healthcare | 10.97% |
| 3 | Industrials | 9.96% |
| 4 | Financials | 9.73% |
| 5 | Consumer Staples | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Church & Dwight Co
CHD
$23.1B
| $893K | 0.05% |
12,702
-35
| -0.3% | -$2.49K |
|
277
WisdomTree US SmallCap Dividend Fund
DES
$2.19B
| $887K | 0.05% |
30,914
| – | – |
|
278
Ingredion
INGR
$6.33B
| $887K | 0.05% |
9,541
+8,264
| +647% | +$694K |
|
279
First Solar
FSLR
$22.1B
| $881K | 0.05% |
15,742
-6,420
| -29% | -$353K |
|
280
Applied Materials
AMAT
$398B
| $859K | 0.04% |
14,071
+1,898
| +16% | +$107K |
|
281
Genuine Parts
GPC
$17.2B
| $852K | 0.04% |
8,015
-81
| -1% | -$8.33K |
|
282
Morgan Stanley
MS
$330B
| $846K | 0.04% |
16,552
-57
| -0.3% | -$2.7K |
|
283
iShares Russell 1000 Value ETF
IWD
$81.8B
| $841K | 0.04% |
6,163
+205
| +3% | +$27K |
|
284
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.2B
| $835K | 0.04% |
6,090
-526
| -8% | -$69.7K |
|
|
CHI
285
Calamos Convertible Opportunities and Income Fund
CHI
$999M
| $829K | 0.04% |
75,378
+200
| +0.3% | +$2.15K |
|
286
Elevance Health
ELV
$81.6B
| $809K | 0.04% |
2,681
-123
| -4% | -$33.8K |
|
|
SPPP
287
Sprott Physical Platinum and Palladium Trust
SPPP
$587M
| $806K | 0.04% |
+56,039
| New | +$746K |
|
288
McKesson
MCK
$101B
| $794K | 0.04% |
5,743
+5
| +0.1% | +$707 |
|
289
ResMed
RMD
$30.3B
| $788K | 0.04% |
5,084
+27
| +0.5% | +$3.89K |
|
290
Chemed
CHE
$7.1B
| $780K | 0.04% |
1,775
+28
| +2% | +$11.8K |
|
291
Cintas
CTAS
$82.7B
| $776K | 0.04% |
11,540
+2,620
| +29% | +$172K |
|
292
Bio-Rad Laboratories Class A
BIO
$8.74B
| $763K | 0.04% |
2,062
| – | – |
|
|
SGI
293
Somnigroup International
SGI
$14.1B
| $753K | 0.04% |
+34,596
| New | +$723K |
|
294
Yum China
YUMC
$15.9B
| $751K | 0.04% |
15,645
+450
| +3% | +$20K |
|
295
WD-40
WDFC
$3.06B
| $750K | 0.04% |
3,861
-429
| -10% | -$80.8K |
|
296
Vanguard FTSE Pacific ETF
VPL
$8.16B
| $749K | 0.04% |
10,770
-9,800
| -48% | -$672K |
|
297
Ecolab
ECL
$78.6B
| $742K | 0.04% |
3,848
+2,248
| +141% | +$427K |
|
298
AB InBev
BUD
$166B
| $741K | 0.04% |
9,033
-620
| -6% | -$51.6K |
|
299
US Foods
USFD
$22.1B
| $741K | 0.04% |
17,690
+15,405
| +674% | +$618K |
|
300
Enterprise Products Partners
EPD
$82.5B
| – | – |
0
| – | – |
|
Similar funds
JIM
LFG
VT
NC
CS
EIC
AC
CIA
Central Trust Company's Q4 2019 Portfolio in Review
As of Q4 2019, Central Trust Company held 1,252 positions worth $1.95B, up 10% from $1.77B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Central Trust Company's Q4 2019 filing shows 88 new, 327 increased, 360 reduced and 74 closed positions. Its largest new stake was State Street SPDR S&P 600 Small Cap Value ETF: 46,588 shares worth $3.06M. The largest sale was Celgene Corp, an estimated $6.79M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.
- Central Trust Company's largest Q4 2019 buy was State Street SPDR S&P 600 Small Cap Value ETF: 46,588 shares worth $3.06M.
- Central Trust Company added most to Vanguard Morningstar Mid-Cap Value ETF in Q4 2019, an estimated $4.63M increase.
- Central Trust Company's biggest Q4 2019 reduction was Apple, cutting an estimated $2.01M.
- Central Trust Company fully exited Celgene Corp in Q4 2019, selling an estimated $6.79M.
- Central Trust Company's ten largest holdings make up 25% of its $1.95B portfolio in Q4 2019.
- Central Trust Company opened 88 new positions and closed 74 in Q4 2019.
- Central Trust Company's portfolio value rose 10% quarter-over-quarter to $1.95B.
Based on Central Trust Company's 13F filing for Q4 2019, filed 21 Jan 2020.